CITIGROUP INC - EIGER BIOPHARMACEUTICALS INC ownership

EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 57 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
CITIGROUP INC ownership history of EIGER BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$1,140
-57.6%
3,737
-2.1%
0.00%
Q2 2023$2,689
-12.7%
3,819
+11.1%
0.00%
Q1 2023$3,081
-77.7%
3,436
-70.6%
0.00%
Q4 2022$13,798
-56.9%
11,693
+178.6%
0.00%
Q3 2022$32,000
-36.0%
4,197
-46.9%
0.00%
Q2 2022$50,0000.0%7,904
+29.8%
0.00%
Q1 2022$50,000
-33.3%
6,088
-57.9%
0.00%
Q4 2021$75,000
+13.6%
14,458
+45.7%
0.00%
Q3 2021$66,0000.0%9,921
+26.9%
0.00%
Q2 2021$66,000
-8.3%
7,815
-4.5%
0.00%
Q1 2021$72,000
-90.9%
8,179
-87.3%
0.00%
Q4 2020$791,000
+61.8%
64,316
+7.1%
0.00%
Q3 2020$489,000
-15.8%
60,027
-0.9%
0.00%
Q2 2020$581,000
+34.5%
60,556
-4.7%
0.00%
Q1 2020$432,000
+332.0%
63,553
+844.0%
0.00%
Q4 2019$100,000
+426.3%
6,732
+247.2%
0.00%
Q3 2019$19,000
-75.0%
1,939
-73.3%
0.00%
Q2 2019$76,000
-80.7%
7,267
-74.2%
0.00%
Q1 2019$394,000
+39300.0%
28,164
+21075.9%
0.00%
Q4 2018$1,000
-50.0%
1330.0%0.00%
Q3 2018$2,0000.0%1330.0%0.00%
Q2 2018$2,000
+100.0%
1330.0%0.00%
Q1 2018$1,000
-50.0%
1330.0%0.00%
Q4 2017$2,000
+100.0%
1330.0%0.00%
Q3 2017$1,0000.0%1330.0%0.00%
Q2 2017$1,000
-75.0%
133
-57.4%
0.00%
Q1 2017$4,000
+100.0%
312
+129.4%
0.00%
Q4 2016$2,0000.0%136
+2.3%
0.00%
Q3 2016$2,000
-81.8%
133
-74.7%
0.00%
Q2 2016$11,000
+266.7%
526
+200.6%
0.00%
Q1 2016$3,0001750.00%
Other shareholders
EIGER BIOPHARMACEUTICALS INC shareholders Q3 2018
NameSharesValueWeighting ↓
Vivo Capital, LLC 1,787,091$14,118,0003.56%
INTERWEST VENTURE MANAGEMENT CO 1,599,592$12,637,0002.99%
SPHERA FUNDS MANAGEMENT LTD. 385,301$3,044,0000.52%
Boxer Capital, LLC 138,331$1,093,0000.26%
DAFNA Capital Management LLC 35,977$284,0000.20%
SABBY MANAGEMENT, LLC 223,100$1,762,0000.12%
Hikari Power Ltd 60,992$482,0000.06%
Perceptive Advisors 157,679$1,245,0000.06%
Lombard Odier Asset Management (USA) Corp 90,000$711,0000.06%
TFS CAPITAL LLC 12,128$96,0000.04%
View complete list of EIGER BIOPHARMACEUTICALS INC shareholders